Related Experiment Video
Updated: Apr 10, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis
Anna Licata1, Giuseppina Novo, Daniela Colomba
1aSezione di Gastroenterologia ed Epatologia bSezione di Medicina Clinico-Sperimentale, Dipartimento di Medicina Interna e Specialistica, DIBIMIS, Università di Palermo, Italy cDivisione di Cardiologia dSezione di Radiologia, Dipartimento di Biopatologia e Biotecnologie Mediche, DiBiMEF, Università di Palermo, Palermo, Italy.
Insights
Cirrhotic cardiomyopathy, a condition in patients with chronic liver disease, involves heart dysfunction despite traditional beliefs of cardiac protection. This review details its features, diagnosis, and biomarkers.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Traditionally, the cirrhotic heart was considered protected from cardiovascular disease.
- Recent evidence indicates chronic liver disease patients face increased cardiovascular events.
- Decompensated cirrhosis leads to hemodynamic changes, termed hyperdynamic syndrome, causing cirrhotic cardiomyopathy.
Purpose of the Study:
- To review the clinical and diagnostic features of cirrhotic cardiomyopathy.
- To discuss associated comorbidities, diagnostic hallmarks, and potential biomarkers.
- To provide a comprehensive overview of cardiac involvement in cirrhosis.
Main Methods:
- Literature review of studies on cirrhotic cardiomyopathy.
- Analysis of clinical presentation and diagnostic criteria.
- Examination of echocardiographic, electrocardiographic, and cardiac magnetic resonance findings.
- Evaluation of serum biomarkers for diagnostic utility.
Main Results:
- Cirrhotic cardiomyopathy is characterized by subclinical systolic dysfunction, impaired diastolic function, and electrophysiological abnormalities.
- The hyperdynamic syndrome is a key hemodynamic feature in decompensated cirrhosis.
- Diagnostic hallmarks include specific findings on echocardiography, ECG, and cardiac MRI.
- Serum biomarkers show potential for diagnosing cirrhotic cardiomyopathy.
Conclusions:
- Cirrhotic cardiomyopathy is a significant complication of chronic liver disease, contrary to traditional views.
- Early recognition and diagnosis are crucial for managing cardiovascular risk in these patients.
- Further research into serum biomarkers may enhance diagnostic accuracy and patient outcomes.
Abstract:
Cirrhotic heart has been traditionally considered protected from cardiovascular disease, even if a large amount of literature has recently shown that patients affected by chronic liver disease are exposed to cardiovascular events, as well. Since the first recognition of cardiac involvement in cirrhosis, all published studies explain that decompensated cirrhotic patients suffer from haemodynamic changes, currently known as hyperdynamic syndrome, which finally lead to cirrhotic cardiomyopathy. This is defined by the presence of a subclinical systolic dysfunction unmasked under stress conditions, impaired diastolic function and electrophysiological abnormalities, in the absence of any known cardiac disease. In this review, we will discuss the clinical and diagnostic features of this condition, the prevalence of associated comorbidities, echocardiographic, electrocardiographic and cardiac magnetic resonance hallmarks and the possible diagnostic role of serum biomarkers.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy